W. D. Schoppe

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

P. Meusers, M. Engelhard, H. Bartels et al. · Hematological Oncology · 1989 · 172 citations

Medicine, Oncology, Pharmacology +16

Prognostic risk factors in advanced Hodgkin's lymphoma

Markus Loeffler, Michael Pfreundschuh, Dirk Hasenclever et al. · Annals of Hematology · 1988 · 45 citations

Medicine, Oncology, Pathology +9

Risk Factor Adapted Treatment of Hodgkin’s Lymphoma: Strategies and Perspectives

Markus Loeffler, Michael Pfreundschuh, U Rühl et al. · Recent results in cancer research/Recent Results in Cancer Research · 1989 · 20 citations

Medicine, Oncology, Chemotherapy +12

Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group

Volker Diehl, Michael Pfreundschuh, Markus Löffler et al. · Medical Oncology and Tumor Pharmacotherapy · 1989 · 20 citations

Medicine, Oncology, Pharmacology +12

Therapie der Hodgkin-Lymphome

M. Pfreundschuh, Markus Löffler, U Rühl et al. · Onkologie · 2009 · 13 citations

Medicine, Hematology, Oncology +7